ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML
Product details
Registration number: SIN16408P
Classification: Prescription Only
Active ingredients: Pegaspargase
Strength: 750 U/ml
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: SERVIER (S) PTE LTD
ATC code: L01XX24
HSA approval date: 27 December 2021
Manufacturer(s): Lyophilization Services of New England, Inc.
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16408P
Classification: Prescription Only
What active ingredients and strength are recorded for ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Pegaspargase
Strength: 750 U/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: SERVIER (S) PTE LTD
Which manufacturers and countries are listed for ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Lyophilization Services of New England, Inc.
Manufacturing country/countries: UNITED STATES
Where can I look up ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16408P or the exact product name ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML. The general register link does not preselect this product.
What are the source dates for this ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16408P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)